A review of the venous thrombotic issues associated with multiple myeloma-Reference-Cited by-同舟云学术

A review of the venous thrombotic issues associated with multiple myeloma

Published:2016-06-08 Issue:7 Volume:9 Page:695-706
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Fotiou Despina¹,Gerotziafas Grigoris²³,Kastritis Efstathios¹,Dimopoulos Meletios A.¹,Terpos Evangelos¹

Affiliation:

1. Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

2. INSERM U938, Faculté de Médecine Pierre et Marie Curie, Université Paris VI, Paris, France

3. Thrombosis Center, Service d’Hématologie Biologique Hôpital Tenon, Hôpitaux Universitaires de l’Est Parisien, Assistance Publique Hôpitaux de Paris, Paris, France

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2016.1194750

Reference87 articles.

1. Epidemiology, risk and outcomes of venous thromboembolism in cancer

2. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006

3. Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies

4. International Association for Research on Cancer (IARC). Estimated incidence and mortality of multiple myeloma and immunoproliferative diseases in Europe in 2012 (both sexes). [cited 2015 Dec 12]. Available from: http://eco.iarc.fr/eucan/Cancer.aspx?Cancer=39

5. Surveillance Epidemiology and End Results SEER 2006-2010. [cited 2015 Nov 15]. Available from: http://www.seer.cancer.gob/statfacts/html/mulmy.html.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rediscovering hemostasis abnormalities in multiple myeloma: The new era;Heliyon;2024-07

2. Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials;Therapeutic Advances in Medical Oncology;2024-01

3. Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma;Thrombosis Journal;2023-10-04

4. Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system;Frontiers in Pharmacology;2022-12-01

5. Development and validation of a new risk assessment model for immunomodulatory drug- associated venous thrombosis among Chinese patients with multiple myeloma;2022-10-19